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Abstract
Background: Tyrosine hydroxylase (TH) activity and its possible participation in the control of
insulin secretion were studied in pancreatic islets of adult Wistar rats fed a standard commercial
diet (SD) or carbohydrates alone (CHD) for one week. TH activity, norepinephrine (NE) content,
and glucose-induced insulin secretion were assessed. Blood glucose and insulin levels were
measured at the time of sacrifice.
Results: CHD rats had significantly higher blood glucose and lower insulin levels than SD rats
(114.5 ± 6.7 vs 80.7 ± 7.25 mg/dl, p < 0.001; 20.25 ± 2.45 vs 42.5 ± 4.99 µU/ml, p < 0.01,
respectively). Whereas TH activity was significantly higher in CHD isolated islets (600 ± 60 vs 330
± 40 pmol/mg protein/h; p < 0.001), NE content was significantly lower (18 ± 1 vs 31 ± 5 pmol/mg
protein), suggesting that TH activity would be inhibited by the end-products of catecholamines
(CAs) biosynthetic pathway. A similar TH activity was found in control and solarectomized rats
(330 ± 40 vs 300 ± 80 pmol/mg protein/h), suggesting an endogenous rather than a neural origin of
TH activity. CHD islets released significantly less insulin in response to glucose than SD islets (7.4
± 0.9 vs 11.4 ± 1.1 ng/islet/h; p < 0.02).
Conclusions: TH activity is present in islet cells; dietary manipulation simultaneously induces an
increase in this activity together with a decrease in glucose-induced insulin secretion in rat islets.
TH activity – and the consequent endogenous CAs turnover – would participate in the paracrine
control of insulin secretion.
Background
The presence of monoamines in the endocrine pancreas
has been reported by several authors in different animals
using either histochemical or chemical procedures [1–3],
even in islets obtained from chemically sympathect-
omized mice [4].
Islet cells have also been shown to contain enzymes in-
volved both in catecholamine (CAs) synthesis (tyrosine
hydroxylase, TH [5–7], and dihydroxyphenylalanine,
DOPA, decarboxylase [6–9]) and inactivation (monoam-
ine oxidase, MAO [10–12]). The increase in islet CAs con-
tent in animals previously treated with precursors of CAs
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actively involved in CAs turnover in islet cells.
The increment of islet CAs – induced by the administra-
tion of their precursors – significantly modified the re-
lease of insulin, suggesting that endogenous CAs can
affect islet function [14]. In support of this assumption we
have recently reported that: a) Glucose induces a selective
release of CAs by isolated islets, b) TH inhibition by a spe-
cific inhibitor increased the glucose-induced insulin secre-
tion from isolated islets in fresh and precultured islets,
and c) Addition of α and β adrenergic receptor blockers
significantly affected the secretion of insulin elicited by
glucose [15]. To assess the physiological significance of
these results it remains to be elucidated whether they can
be reproduced at least partially in vivo.
The present study was designed to gain further insight into
the possible role of islet TH in CAs synthesis and insulin
secretion in vivo. Therefore, we tested whether dietary ma-
nipulation of normal rats fed only with carbohydrates can
modify TH activity, CA content, as well as content and in-
sulin release from isolated islets.
Materials and Methods
Chemicals and drugs
Collagenase was obtained from Serva Feinbiochemica
(Heidelberg, Germany); bovine serum albumin fraction V
(BSA) and other reagents of the purest available grade
were from Sigma Chemical Co. (St. Louis, MO, USA).
Animals and diets
Normal male Wistar rats (180–200 g) were maintained in
a temperature-controlled environment (23°C) with a
fixed 12 h light:12 h darkness cycle. The animals were di-
vided into two groups: the intervention group received a
carbohydrate diet (CHD) containing 44% glucose plus
56% starch (starch composition = carbohydrates:pro-
teins:lipids 27:3.1:0.4) for a week, whereas control rats re-
ceived a commercial standard diet (SD) containing
carbohydrates:proteins:lipids 45:43:12 for the same peri-
od. The animals had free access to food and water
throughout the experiment. Both weight and food intake
were recorded for each individual animal every 48 h dur-
ing the experimental period.
Serum glucose and insulin determinations
Blood samples from both groups of animals were ob-
tained from the retro-orbital plexus under light ether an-
esthesia early in the morning. Serum glucose was
determined by the glucose-oxidase GOD-PAP method
(Roche Diagnostics, Mannheim, Germany) and insulin
levels were determined by radioimmunoassay (RIA) [16].
Islet isolation and incubation
Pancreatic islets from SD and CHD rats were isolated by
the collagenase method of Lacy and Kostianovsky [17].
Groups of five islets from both groups were incubated for
60 min at 37°C in 600 µl Krebs-Ringer-bicarbonate buffer
with 1% (w/v) BSA, Trasylol™ (400 IU/ml), and either 3.3
or 16.7 mM glucose [18]. The medium had been previous-
ly gassed with a mixture of CO2/O2 (5%/95%) (v/v) to ad-
just the pH to 7.4; aliquots were obtained from the
medium at the end of the incubation period and kept fro-
zen until insulin determination by RIA [16].
Islet insulin content
Groups of 20 isolated islets were placed in 400 µl H2O.
After disruption by ultrasound for 15 s, the samples were
diluted with two volumes of 30% (v/v) acetic acid. Suita-
ble further aliquots at appropriate dilutions were then
used to measure insulin levels by RIA [16].
TH activity assay
SD and CHD islets were placed in a tube containing
Locke's solution and then disrupted with a glass homoge-
nizer in a 150 mM KCl solution (1/10 [w/v]) in the cold.
Of this homogenate, 150 µl were used as the source of en-
zyme in all experiments. The incubation medium had the
following composition (in a total volume of 0.5 ml): 400
mM sodium-acetate buffer, pH 6.1; 1.0 mM FeSO4 40 mM
2-mercaptoethanol; 100 µM or 2.0 mM DMPH4(2-ami-
no-4-hydroxy-6,7-dimethyl-5,6,7,8-tetrahydropteridine
hydrochloride); 2.0 mM sodium phosphate; 15 units/ml
DOPA decarboxylase; 10 µM pyridoxal phosphate; 100
µM [1-14C]L-tyrosine (10 Ci/mol, New England Nuclear
Corporation, Boston, USA). Blanks were obtained by per-
forming the assay in the presence of 2 mM of the inhibitor
3-iodotyrosine in the incubation medium. The reaction
was carried out for 30 min at 37°C with continuous shak-
ing in a 10 ml Erlenmeyer flask covered with a rubber in-
jection-vial stopper from which a plastic well was
suspended containing a folded paper impregnated with
0.2 ml NCS (Nuclear Chicago solubilizer) in order to trap
the 14CO2 formed in the decarboxylation step of the assay
[19].
The reaction was stopped by injecting 0.5 ml of 10% (v/v)
trichloroacetic acid into the flask. The incubation was next
resumed for 2 h at 37°C with continuous shaking to trap
the 14CO2 released by the enzymic reactions. The plastic
wells were then removed, wiped with absorbent tissue,
and placed in 10 ml toluene scintillation fluid containing
0.6 g 1,4-bis-[2 (5-phenyloxazolyl)]benzene (POPOP), 4 g
2,5-diphenyloxazole (PPO), and 5 ml ethanol per liter of
toluene. The samples were finally counted in a liquid-
scintillation spectrometer.Page 2 of 6
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NE was partially purified by batch alumina extraction,
separated by reverse-phase HPLC on a 4.6 X 250-mm Zor-
bax RP C 18 column (DuPont), and quantified ampero-
metrically with a triple-electrode system (ESA, Bedford,
NA) by measuring the current produced upon exposure of
the column effluent to first oxidizing and then reducing
potentials in series. CAs recovery through the alumina-ex-
traction step averaged some 70–80%, as estimated
through the use of dihydroxybenzylamine as internal
standard [20].
Data analysis
For the statistical evaluation of the data, we used both var-
iance analysis and the paired Student's t-test.
Results
Although both groups of rats ate comparable amounts of
their respective diets, there was an 8% body weight in-
crease in the SD group (214.3 ± 4.1 to 231.7 ± 4.4 g),
while CHD animals underwent a 13% weight loss (270.7
± 7.6 to 233.8 ± 6.3 g). The caloric content of the daily
food consumed per animal was significantly lower in
CHD rats (58.8 ± 3.5 vs 152 ± 15.2 Cal/d, p < 0.01)
Serum glucose and insulin levels measured at the time of
sacrifice were significantly higher and lower, respectively,
in the CHD than in the SD group (glucose, 114.5 ± 6.7 (n
= 6) vs 80.7 ± 7.25 (n = 6) mg/dl, p < 0.001; insulin, 20.25
± 2.45 vs 42.5 ± 4.99 µU/ml, p < 0.01).
Figure 1
Effect of CHD upon TH activity (pmol/mg protein/h) [panel A], and NE content (pmol/mg prot) [panel B] of normal rat isolated 
islets of Langerhans (SD, open bars; CHD, hatched bars). Each bar represents the mean ± SEM. n, above the corresponding 
bar. P values: TH activity, p < 0.001; NE content, p < 0.05.
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that of SD controls (Fig. 1A, p < 0.001). Conversely, no
significant differences between these two groups were ob-
served when TH activity was measured in samples of car-
diac muscle (data not shown). Similar TH activity values
were measured in previous control experiments in islets
isolated from normal (N) or solarectomized (S) rats (N =
330 ± 40 vs S = 300 ± 80 pmol/mg prot/h).
NE content of islets obtained from CHD rats was signifi-
cantly lower than that of SD animals (Fig 1B; p < 0.05).
Islets isolated from both groups released more insulin in
response to 16.7 than 3.3 mM glucose (p < 0.001); how-
ever, islets from CHD animals released significantly less
insulin in the presence of high glucose than did those
from SD rats (p < 0.02). By contrast, a similar insulin out-
put by the islets of both groups was observed in response
to 3.3 mM glucose (Fig. 2). However, the insulin content
of nonincubated islets freshly isolated from CHD rats was
significantly higher than that SD rat islets (Fig 2, inset; p <
0.05).
Discussion
Teitelman et al. [21] originally demonstrated the immu-
nocytochemical presence of TH in glucagon- and insulin-
secreting cells of the fetal mouse pancreas and its disap-
pearance after birth. Using the same method, however,
Iturriza & Thibault [5] detected TH in B-cells of Sprague
Dawley rats, two strains of mice, and pigmented guinea
Figure 2
Effect of CHD upon insulin secretion (ng/islet/h) of isolated normal rat islets incubated in the presence of 3.3 or 16.7 mM glu-
cose (SD, open bars; CHD, hatched bars). Each bar represents the mean ± SEM. n, above the corresponding bar. P values: a vs 
c and b vs d, p < 0.001; c vsd, p < 0.02. Inset: Insulin content of nonincubated islets isolated from animals of the indicated group. 
Each bar represents the mean ± SEM, n above the corresponding bar. P < 0.005.
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lian endocrine pancreas was not necessarily a transient
phenomenon.
Our study is the first to demonstrate a measurable and
modulated TH activity in the endocrine pancreas of nor-
mal adult rats. Since similar TH activity values were re-
corded in islets isolated from S and SD rats, the enzyme
activity measured was of islet rather than neural origin.
The increase in islet TH activity measured in our CHD is-
lets could be ascribed to the reported stimulatory effect of
this type of diet upon the sympathetic activity and on pan-
creatic – and other tissues as well – NE turnover [22] in
man and rats [23]. However, the fact that this diet did not
affect TH activity in cardiac muscle would indicate a selec-
tive effect upon islet CAs. The possibility that CAs metab-
olism exhibits a lower response threshold to dietary
manipulations in islets than in other peripheral tissues
cannot be ruled out.
In CHD animals, the increased islet TH activity was ac-
companied by a decreased NE content [24]. In other tis-
sues, the limiting step in CA biosynthesis is the conversion
of tyrosine to DOPA by TH [25], being this reaction inhib-
ited by the end products of the biosynthetic pathway [26].
Thus, though with caution, we could assume that a similar
regulatory mechanism would also operate in vivo in nor-
mal islets. However, we cannot assure that exposure to the
diet for a week would not induce TH synthesis de novo
[26].
The islets from CHD animals released less insulin than
those from SD rats when incubated with 16.7 mM glu-
cose. This lower response was not secondary to a decrease
in the storage of the hormone, since the islets from CHD
rats contained a higher concentration of insulin than did
those from the SD group. These results are consistent with
those reporting that monoamines in B cells do not influ-
ence insulin storage [27]. The significantly higher blood
glucose and lower insulin levels measured in CHD ani-
mals would represent the in vivo counterpart of the lower
capacity of their islets to release insulin in response to glu-
cose in vitro. These results are also consistent with our re-
port that a specific TH inhibitor increased significantly the
glucose-induced insulin release either in fresh or precul-
tured incubated islets [15], suggesting that the phenome-
non could also occur in vivo. However, we cannot rule out
that the caloric restriction and the protein deficiency in
CHD animals could also affect through another mecha-
nism the in vitro glucose-induced insulin secretion in this
group of rats [28,29].
Altogether, our results are consistent with the following
conclusions: a) TH activity in pancreatic islets can be
modified, at least by dietary manipulation; b) As in other
tissues, the activity of the enzyme would be inhibited by
the end products of the CA biosynthetic pathway, and c)
Changes in TH activity of isolated islets are accompanied
by significant alterations in the amount of insulin released
in vitro in response to glucose, a functional association
that may also occur in vivo. These findings, together with
those previously reported [15], would indicate that en-
dogenously-generated islet CAs might well participate in
the paracrine control of insulin secretion.
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